论文部分内容阅读
目的 :探讨使用新辅助化疗联合保乳术治疗乳腺癌的效果。方法 :选取我院2010年6月~2014年6月期间收治的80例乳腺癌患者作为研究对象。根据患者的意愿将其分为对照组和观察组,每组各40例患者。为对照组患者使用传统的乳腺癌根治术进行治疗,为观察组患者使用新辅助化疗联合保乳术进行治疗,然后比较两组患者治疗的效果。结果 :观察组患者治疗的总有效率、手术持续的时间、术中出血量、术后住院的时间均明显优于对照组患者,差异显著,具有统计学意义(P<0.05)。两组患者病情的复发率及远处转移率无显著性差异,无统计学意义(P>0.05)结论 :使用新辅助化疗联合保乳术治疗乳腺癌效果显著,患者手术持续的时间短,术中出血量少,身体状态恢复较好,可有效地缩短其住院的时间。此治疗方法值得在临床上推广应用。
Objective: To investigate the effect of neoadjuvant chemotherapy and breast-conserving surgery on breast cancer. Methods: Eighty cases of breast cancer who were treated in our hospital from June 2010 to June 2014 were selected as the research object. According to the wishes of patients will be divided into control group and observation group, each group of 40 patients. The control group of patients treated with conventional radical mastectomy for the observation group were treated with neoadjuvant chemotherapy combined with breast-conserving surgery, and then compared the efficacy of treatment in both groups. Results: The total effective rate of treatment, duration of operation, blood loss during operation and postoperative hospital stay in observation group were significantly better than those in control group, with significant difference (P <0.05). There was no significant difference between the two groups in the recurrence rate and the distant metastasis rate (P> 0.05) .Conclusion: Neoadjuvant chemotherapy combined with breast conserving surgery is effective in treating breast cancer. The duration of surgery is short, Less bleeding, the body recovered better, which can effectively reduce the length of their hospital stay. This treatment is worth promoting in clinical application.